Krishnan Krish S, President and CEO, Director, 10% Owner at Krystal Biotech, Inc., sold $300K of KRYS
This page documents an SEC Form 4 insider trading disclosure for $KRYS securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Krishnan Krish S |
|---|---|
| Title | President and CEO, Director, 10% Owner |
| Company | Krystal Biotech, Inc. |
| Ticker | KRYS |
| Transaction Type | Sale |
| Transaction Date | 2026-06-04 |
| Shares Traded | 964 |
| Price Per Share | $311.358 |
| Total Value | $300K |
| Filed Date | 2026-06-05 |
| Accession Number | 0001298709-26-000009 |
Ownership Context
| Shares Owned After Transaction | 1,450,293 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001298709-26-000009
Other Insider Trades — KRYS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Thomas John Charles | EVP, General Counsel | traded | $179K | 2026-06-25 |
| Thomas John Charles | EVP, General Counsel | sold | $347K | 2026-06-25 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $179K | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $122K | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $147K | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $414K | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $1.2M | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $3.9M | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $868K | 2026-06-04 |
| Krishnan Suma | President, R&D, Director, 10% Owner | sold | $75K | 2026-06-04 |
Other Trades by Krishnan Krish S
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | sold | $96K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $193K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $53K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $166K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $180K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $3.5M | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $1.5M | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $862K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $823K | 2026-06-04 |
| KRYS | Krystal Biotech, Inc. | sold | $12K | 2026-06-04 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for KRYS — Krystal Biotech, Inc. →
Whisper Score — KRYS
Track KRYS insider activity in real time on The Wire →
Get alerts when Krishnan Krish S files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:19 UTC